Hepatocyte Growth Factor Induces Resistance to Anti-Epidermal Growth Factor Receptor Antibody in Lung Cancer-Reference-Cited by-同舟云学术

Hepatocyte Growth Factor Induces Resistance to Anti-Epidermal Growth Factor Receptor Antibody in Lung Cancer

Published:2012-02 Issue:2 Volume:7 Page:272-280
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Yamada Tadaaki,Takeuchi Shinji,Kita Kenji,Bando Hideaki,Nakamura Takahiro,Matsumoto Kunio,Yano Seiji

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference42 articles.

1. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

2. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan;Ohe;Ann Oncol,2007

3. Epidermal growth factor-related peptides and their receptors in human malignancies;Salomon;Crit Rev Oncol Hematol,1995

4. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung;Rusch;Cancer Res,1993

5. Signaling through the epidermal growth factor receptor during the development of malignancy;Grandis;Pharmacol Ther,2004

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporaneous Perioperative Inflammatory and Angiogenic Cytokine Profiles of Surgical Breast, Colorectal, and Prostate Cancer Patients: Clinical Implications;Cells;2023-12-04

2. Menin Maintains Cholesterol Content in Colorectal Cancer via Repression of LXR-Mediated Transcription;Cancers;2023-08-16

3. Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling;Cancers;2023-01-11

4. Tumor immune microenvironment in epidermal growth factor receptor-mutated non-small cell lung cancer before and after epidermal growth factor receptor tyrosine kinase inhibitor treatment: a narrative review;Translational Lung Cancer Research;2021-09

5. When the MET receptor kicks in to resist targeted therapies;Oncogene;2021-05-24